Changyu Wang

1095 Jiefang Ave
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Contrast-Enhanced Computed Tomography Radiomics Predicts Colony-Stimulating Factor 3 Expression and Clinical Prognosis in Ovarian Cancer.

Contrast-Enhanced Computed Tomography Radiomics Predicts Colony-Stimulating Factor 3 Expression and Clinical Prognosis in Ovarian Cancer.

Journal: Academic radiology

Published: September 25, 2024

High Expression of TBC1 Domain Family Member 22A is Related to Poor Prognosis in Ovarian Serous Cystadenocarcinoma.

High Expression of TBC1 Domain Family Member 22A is Related to Poor Prognosis in Ovarian Serous Cystadenocarcinoma.

Journal: International journal of medical sciences

Published: June 17, 2024

Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia.

Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia.

Journal: Journal of gynecologic oncology

Published: June 20, 2023

Oncologic and reproductive outcomes after fertility-sparing surgery for bilateral borderline ovarian tumors: A retrospective study.

Oncologic and reproductive outcomes after fertility-sparing surgery for bilateral borderline ovarian tumors: A retrospective study.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: June 19, 2023

Low expression of acyl-CoA thioesterase 13 is associated with poor prognosis in ovarian serous cystadenocarcinoma.

Low expression of acyl-CoA thioesterase 13 is associated with poor prognosis in ovarian serous cystadenocarcinoma.

Journal: Frontiers in genetics

Published: April 27, 2023

A novel hypoxia-stimulated lncRNA HIF1A-AS3 binds with YBX1 to promote ovarian cancer tumorigenesis by suppressing p21 and AJAP1 transcription.

A novel hypoxia-stimulated lncRNA HIF1A-AS3 binds with YBX1 to promote ovarian cancer tumorigenesis by suppressing p21 and AJAP1 transcription.

Journal: Molecular carcinogenesis

Published: April 08, 2023

WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade.

WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade.

Journal: Cancer science

Published: April 29, 2021

Integrative analysis of the common genetic characteristics in ovarian cancer stem cells sorted by multiple approaches.

Integrative analysis of the common genetic characteristics in ovarian cancer stem cells sorted by multiple approaches.

Journal: Journal of ovarian research

Published: July 18, 2020

Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients.

Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients.

Journal: BMC cancer

Published: March 14, 2020

Corrigendum to "Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution" [Surgical oncology 31 (2019) 8-13/SURGONC_2019_170].

Corrigendum to "Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution" [Surgical oncology 31 (2019) 8-13/SURGONC_2019_170].

Journal: Surgical oncology

Published: November 01, 2019

Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.

Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.

Journal: Surgical oncology

Published: April 24, 2019

A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients.

A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients.

Journal: BMC cancer

Published: April 16, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026